ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $99K of Arcutis Biotherapeutics, Inc.
Sold$98,696
$9.87Price
10,000Shares
−5%Stake
What ARQT did after the filing
- The stock from Tue, Aug 6 open, $9.10
- +14.3%
- S&P 500, same days
- +8.1%
Measured over 30 trading days, to the Sep 18 close.
Traded Thu, Aug 1. Filed Mon, Aug 5, 4:37 PM ET, after the close. Returns use the Aug 6 open and the Sep 18 close. Not investment advice.